Active Transport, Cell Nucleus

"Active Transport, Cell Nucleus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE.

Descriptor ID	D021581
MeSH Number(s)	G03.143.310.100 G03.143.700.100
Concept/Terms	Active Transport, Cell Nucleus Active Transport, Cell Nucleus Nucleo-cytoplasmic Transport Nucleo cytoplasmic Transport Transport, Nucleo-cytoplasmic Transports, Nucleo-cytoplasmic Nucleocytoplasmic Transport Transport, Nucleocytoplasmic Nuclear Transport Transport, Nuclear Nuclear Import Nuclear Import Import, Nuclear Nuclear Export Nuclear Export Export, Nuclear

Below are MeSH descriptors whose meaning is more general than "Active Transport, Cell Nucleus".

Biological Sciences [G]
Metabolism [G03]
Biological Transport [G03.143]
Biological Transport, Active [G03.143.310]
Active Transport, Cell Nucleus [G03.143.310.100]
Protein Transport [G03.143.700]
Active Transport, Cell Nucleus [G03.143.700.100]

Below are MeSH descriptors whose meaning is related to "Active Transport, Cell Nucleus".

Below are MeSH descriptors whose meaning is more specific than "Active Transport, Cell Nucleus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Active Transport, Cell Nucleus" by people in this website by year, and whether "Active Transport, Cell Nucleus" was a major or minor topic of these publications.

Bar chart showing 43 publications over 17 distinct years, with a maximum of 7 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	1	1
2002	2	5	7
2003	2	2	4
2005	0	2	2
2006	0	3	3
2007	0	1	1
2008	0	2	2
2009	0	5	5
2010	1	4	5
2011	0	1	1
2012	0	4	4
2013	0	1	1
2014	0	2	2
2015	1	0	1
2020	0	1	1
2021	0	1	1
2024	0	2	2

Below are the most recent publications written about "Active Transport, Cell Nucleus" by people in Profiles.

Hayashi M, Girdhar A, Ko YH, Kim KM, DePierro JA, Buchler JR, Arunprakash N, Bajaj A, Cingolani G, Guo L. Engineered NLS-chimera downregulates expression of aggregation-prone endogenous FUS. Nat Commun. 2024 Sep 10; 15(1):7887.

View in: PubMed
Yang R, Ko YH, Li F, Lokareddy RK, Hou CD, Kim C, Klein S, Antol?nez S, Mar?n JF, P?rez-Segura C, Jarrold MF, Zlotnick A, Hadden-Perilla JA, Cingolani G. Structural basis for nuclear import of hepatitis B virus (HBV) nucleocapsid core. Sci Adv. 2024 Jan 12; 10(2):eadi7606.

View in: PubMed
Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, Ramage HR, Cherry S, Jurado KA. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One. 2021; 16(6):e0253089.

View in: PubMed
Roshdy WH, Rashed HA, Kandeil A, Mostafa A, Moatasim Y, Kutkat O, Abo Shama NM, Gomaa MR, El-Sayed IH, El Guindy NM, Naguib A, Kayali G, Ali MA. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739.

View in: PubMed
Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015 Sep 03; 525(7567):56-61.

View in: PubMed
Briot A, Jaroszewicz A, Warren CM, Lu J, Touma M, Rudat C, Hofmann JJ, Airik R, Weinmaster G, Lyons K, Wang Y, Kispert A, Pellegrini M, Iruela-Arispe ML. Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. Dev Cell. 2014 Dec 22; 31(6):707-21.

View in: PubMed
Rodriguez-Bravo V, Maciejowski J, Corona J, Buch HK, Collin P, Kanemaki MT, Shah JV, Jallepalli PV. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell. 2014 Feb 27; 156(5):1017-31.

View in: PubMed
Gold JI, Martini JS, Hullmann J, Gao E, Chuprun JK, Lee L, Tilley DG, Rabinowitz JE, Bossuyt J, Bers DM, Koch WJ. Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process. PLoS One. 2013; 8(3):e57324.

View in: PubMed
Lucas CR, Cordero-Nieves HM, Erbe RS, McAlees JW, Bhatia S, Hodes RJ, Campbell KS, Sanders VM. Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes. J Immunol. 2013 Jan 15; 190(2):723-36.

View in: PubMed
Bodzin AS, Wei Z, Hurtt R, Gu T, Doria C. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation. J Cell Physiol. 2012 Jul; 227(7):2947-52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement